VERA
Vera Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$36.99-3.92%
Price as of Jul 20, 2026
VERA valuation
Vera Therapeutics, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 103.69x
- P/S forward
- 29.05x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.31x
- Price / sales
- —
- Price / cash flow
- -9.06x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- —
- EV / EBITDA
- -5.98x
- EV / EBIT
- -5.56x
- Market cap
- $2.7B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.